News OEM
Supporting your immunoassay portfolio expansion
January 22, 2025
Biomaterials for IGFBP-3 immunoassay development & manufacturing
Insulin Growth Factor Binding Protein 3 (IGFBP-3) is a protein found in circulation and inside cells. It is composed of 264 amino acids and has a molecular weight ranging from 28.7 kDa to 53 kDa[1]. IGFBP-3 belongs to the family of insulin growth factor binding proteins, which includes six major types, from IGFBP-1 to IGFBP-6. The expression of both IGFBP-3 and IGF-1 is stimulated by growth hormone (GH), which encompasses the secretion of IGF-1 to circulation and its binding with IGFBP-3[2].
IGFBP-3 is the most prevalent type in human adult serum and is primarily produced in the liver and other peripheral tissues before being secreted into the bloodstream[2]. IGFBP-3 binds mainly to insulin growth factors (IGFs), acting as a transport protein. It prolongs the half-life of IGFs and regulates their removal from circulation[3].
In clinical laboratory, serum levels of IGFBP-3 are considered useful aid in the diagnosis and monitoring of growth-hormone related clinical conditions like acromegaly and growth hormone deficiency [4].
How Werfen can support you
We can support your immunoassay portfolio expansion in the endocrinology panel by providing specifically designed antibodies to detect IGFBP-3.
Werfen endocrinology portfolio consist of the following products.
Biomaterial | PN | Product Description |
Antibody | 3000-7076 | Anti-IGFBP-3 mAb (BP371m) |
3000-7077 | Anti-IGFBP-3 mAb (BP324m) | |
3000-5316 | Anti-hGH mAb (7) | |
3000-5319 | Anti-hGH mAb (5) | |
3000-5315 | Anti-Cortisol mAb (3) | |
3000-5318 | Anti-Cortisol mAb (4) | |
3421-0000 | Anti-Prolactin mAb (1) | |
3421-0001 | Anti-Prolactin mAb (2) |
[1] Rajaram et al. Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions. Endocrine Reviews. 1997
[2] Allard J et al. IGF-Binding Proteins: Why Do They Exist and Why Are There So Many? Frontiers in Endocrinology. 2018
[3] Haywood et al The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes. Molecular Metabolism. 2019
[4] Bidlingmaier et al. Laboratory investigations in the diagnosis and follow-up of GH-related disorders. Archives of Endocrinology and Metabolism. 2019
NEWS
Latest News
October 24, 2024
September 27, 2024
Please contact us directly via telephone or with the following form.
Tel. +34 93 860 90 00